|
Patients
|
76
|
21
|
55
| |
|
Ages (years)
|
39.2 ± 5.8 (22.0–53.0)
|
40.3 ± 6.0 (29.0–53.0)
|
38.8 ± 5.9 (22.0–50.0)
|
0.331
|
|
Body mass index (kg/m2)
|
19.8 ± 1.8 (17.2–25.4)
|
20.4 ± 2.1 (17.8–25.4)
|
19.6 ± 1.6 (17.2–24.2)
|
0.072
|
|
Subcutaneous fat thickness (mm)
|
11.6 ± 4.8 (3.0–26.0)
|
14.3 ± 5.8 (3.0–26.0)
|
10.6 ± 3.9 (3.0–20.0)
|
0.002*
|
|
Baseline symptom severity scorea
|
52.4 ± 16.1 (21.9–93.8)
|
51.9 ± 16.2 (21.9–87.5)
|
52.6 ± 16.3 (21.9–93.8)
|
0.871
|
|
Main Symptoms
|
|
Bulk effect
|
67
|
20
|
47
|
0.430
|
|
AUB
|
39
|
10
|
29
|
0.799
|
|
Uterus position
|
0.003*
|
|
Anteverted
|
48
|
19
|
29
| |
|
Retroverted
|
28
|
2
|
26
| |
|
Number of fibroid treated (total)
|
2.8 ± 3.1 (1–15)
|
2.6 ± 3.0 (1–12)
|
2.8 ± 3.1 (1–15)
|
0.805
|
|
1fibroid
|
45
|
14
|
31
| |
|
2–5 fibroids
|
18
|
4
|
14
| |
|
6–9 fibroids
|
8
|
2
|
6
| |
|
≥ 10 fibroids
|
5
|
1
|
4
| |
|
Diameter (cm)b
|
6.6 ± 2.6 (2.1–15.1)
|
6.2 ± 2.7 (2.6–15.0)
|
6.7 ± 2.6 (2.1–15.1)
|
0.494
|
|
Volume (ml)b
|
157.3 ± 141.3 (6.0–794.0)
|
156.7 ± 164.7 (37.0–7.094)
|
157.5 ± 133.0 (6.0–637.0)
|
0.983
|
|
Distance (mm)c
|
92.4 ± 17.0 (57.0–133.0)
|
90.7 ± 13.0 (57.0–117.0)
|
93.1 ± 18.3 (63.0–1.033)
|
0.581
|
|
Bowel Displacement Techniqued
| | | |
0.536
|
|
Yes
|
58
|
15
|
43
| |
|
No
|
18
|
6
|
12
| |
|
Location
| | | |
0.669
|
|
Intramural
|
38
|
9
|
29
| |
|
Subserosal
|
21
|
6
|
15
| |
|
Submucosal
|
17
|
6
|
11
| |
